Luis Angel Rodriguez, MD | |
223 Cibecue Circle, San Carlos Phs Indian Hospital, San Carlos, AZ 85550-0208 | |
(928) 475-7219 | |
(928) 475-7370 |
Full Name | Luis Angel Rodriguez |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 223 Cibecue Circle, San Carlos, Arizona |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699119503 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 4301071202 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Luis Angel Rodriguez, MD 223 Cibecue Circle Rd., San Carlos Phs Indian Hospital, San Carlos, AZ 85550-0208 Ph: (928) 475-7219 | Luis Angel Rodriguez, MD 223 Cibecue Circle, San Carlos Phs Indian Hospital, San Carlos, AZ 85550-0208 Ph: (928) 475-7219 |
News Archive
BioMarker Strategies received a $1.5 million SBIR award to develop a pathway-based companion diagnostic test to facilitate the selection of optimal therapy for patients with melanoma. This award was preceded by an NCI award of $200,000 almost two years ago in September 2011.
The U.S. government on Friday formally accepted a recommendation from the National Science Advisory Board for Biosecurity (NSABB) "to publish two controversial studies of the H5N1 avian influenza virus, moving the pair of papers another step closer to publication," ScienceInsider reports.
StemCells, Inc. announced today that it has received a Notice of Allowance and a Notice of Issuance from the U.S. Patent and Trademark Office for two patents claiming technologies for the establishment and maintenance of cell pluripotency (the ability to become any cell in the body, which is the defining attribute of embryonic stem cells), including the reprogramming of cells to create pluripotent stem cells.
New research published online today in Blood, the Journal of the American Society of Hematology (ASH), identifies common genetic variants predominantly found in African Americans that double their risk for blood clots.
New research from Boston Medical Center found that patients experiencing severe COVID-19 symptoms had improved outcomes when administered an Interleukin-6 (IL6ri) inhibitor, sarilumab or tocilizumab, given to mediate severe systemic inflammatory responses.
› Verified 4 days ago
Dr. Douglas E Brinkerhoff, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 223 Cibecue Circle Rd, San Carlos, AZ 85550 Phone: 928-475-7219 | |
Peter Wesley Eaton, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 223 Cibecue Circle Rd, San Carlos, AZ 85550 Phone: 928-475-7219 | |
Theresa A. Covello, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 223 Cibeque Circle Road, San Carlos, AZ 85550 Phone: 928-475-7219 Fax: 928-475-7370 | |
Wen-te Ted Chen, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 223 Cibecue Circle Rd, San Carlos, AZ 85550 Phone: 928-475-7219 | |
Dr. Carlos Duarte, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Vassar Dr Ne, Usphs Indian Hospital, San Carlos, AZ 85550 Phone: 928-475-7190 | |
Karen Sue Heath, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 223 Cibeque Circle Road, San Carlos, AZ 85550 Phone: 928-475-7219 Fax: 928-475-7370 |